|
CRL > Insurance > Stay Informed Stay InformedTo register for CRL's "Reference Point" newsletter: Click Here Press Release:Aplifi & CRL Align to Deliver Electronic Lab Results
CRL's published Research & Development:HbA1c values from 5 to 7% and mortality* HbA1c more lives with added detail Albumin and all-cause mortality* Serum alcohol and CDT (heavy use marker) and mortality* Bilirubin levels and mortality CEA screening of "healthy" adults and mortality* CEA lives and details Lipid tests and ratios as mortality predictors* Cocaine the real risk Smoking (urine continine levels) and mortality risk Glucosurina and mortality risk Liver enzymes in a very large "healthy" cohort (ALT, AST, GGT & AP and mortality* Non-cig tobacco use and mortality *-peer reviewed medical journal article
CRL is a registered trademark of Clinical Reference Laboratory, Inc. |
![]() ![]() ![]() ![]() ![]() |







